29 Apr 2016 11:47
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Imperial Innovations Group Share News (IVO)
IVO Share
Price
IVO Share
News
IVO Share
Chat
IVO Share
Trades
IVO
Live RNS
IVO Share
Charts
IVO Broker
Ratings
IVO Directors
Deals
IVO Financial
Diary
IVO
Fundamentals
IVO Short
Positions
IVO
Media
Imperial Innovations Group Information
- There is currently no data for IVO
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Innovations CEO steps down
Wed, 17th Jul 2013 10:39
Technology commercialisation and investment group Imperial Innovations confirmed that Chief Executive Susan Searle has stepped down after 11 years in the role. Chief investment officer Russ Cummings, who has been a director since the group's flotation in 2006, has taken over as CEO with immediate effect. Cummings has previously worked at Scottish Equity Partners where he was responsible for investment in high growth technology companies. Chairman Martin Knight commented: "During her tenure, Susan Searle transformed the group from an operational division of Imperial College London, as its technology transfer office, to a major independent venture capital and technology licensing business.""Thanks to her efforts, Innovations now has a stable platform from which it can deliver its long-term ventures and licensing business objectives."CJ
More News
8 Feb 2016 07:56
4 Feb 2016 15:50
Small caps news round-up
(ShareCast News) - Forbidden Technologies was celebrating its first contract win for its social video platform on Thursday, after a number of proof-of-concept trials. The AIM-traded technology firm's 'eva' platform described itself as "the real video social network", and allows users to create profi
Read more4 Feb 2016 10:51
Imperial Innovations proposes £100m fundraising
(ShareCast News) - Imperial Innovations, the UK technology commercialisation and investment company, said on Thursday it has proposed a £100m fundraising by way of placing 425p new ordinary shares. The placing of 425p represents a premium of about 8.0% to the mid-market closing price of the group's
Read more26 Jan 2016 09:00
25 Jan 2016 15:21
GSK, AstraZeneca and J&J join forces with universities for tech transfer fund
(ShareCast News) - AstraZeneca, GlaxoSmithKline and Johnson & Johnson and three leading UK universities are joining forces to try to significantly improve the speed that academic scientific research is translated into new medicines. The University of Cambridge, Imperial College London and University
Read more